// App-Quantinova.ai

: SODIUM POLYSTYRENE SULFONATE, PRACTICE PATTERNS AND ASSOCIATED ADVERSE EVENT RISK; A NATIONWIDE ANALYSIS FROM THE SWEDISH RENAL REGISTER

Researchers

Presenter

  • Paola Laureati

Principal Investigators

  • Marie Evans

  • Marco Trevisan

  • Lovisa Schalin

  • Rino Bellocco

  • Manish M Sood

  • Peter Barany

  • Juan Jesus Carrero

Medical Centers

  • Karolinska Institutet, Stockholm, Sweden

  • Vifor Pharma Nordiska AB, Stockholm, Sweden

  • Univ of Ottawa, Ottawa, Canada

Locations

  • Sweden

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • sodium polystyrene sulfonate

Outcome

  • N/A


Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A